Home › Agent Hub › Agent Tools › Part D coverage by drug › Incruse
Agent Tools
Incruse is a brand of umeclidinium. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 3,644 of 5,492 Medicare Part D and Medicare Advantage drug plans (66.4%) list Incruse on their formulary, across 179 of 286 formularies. The most common placement is tier 3 (3,278 plans, 90% of those covering it). 0 of the covering plans require prior authorization (0%), 0 step therapy and 3,615 a quantity limit.
219 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $35, 63 of them $0; 3,425 charge coinsurance instead — median 22% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 3,605 of 5,496 plans covered it (65.6%); 2027: 3,644 of 5,492 (66.4%).
Of 4,367 plans offered in both years, 18 added it to the formulary and 16 dropped it.
Among plans covering it both years, 47 moved it to a higher tier and 231 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 98 |
| Tier 2 | 268 |
| Tier 3 | 3,278 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 184 of 323 | 57% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,070 of 3,200 | 64.7% | 0% |
| Special needs plans (SNP) | 1,390 of 1,969 | 70.6% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 0 of 846 | No tier listed | 0 |
| UnitedHealthcare | 796 of 830 | Tier 3 | 0 |
| Devoted Health | 728 of 728 | Tier 3 | 0 |
| Aetna Medicare | 631 of 631 | Tier 3 | 0 |
| Wellcare | 268 of 268 | Tier 2 | 0 |
| HealthSpring | 226 of 226 | Tier 3 | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 0 of 83 | No tier listed | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 77 of 77 | Tier 3 | 0 |
| Anthem Blue Cross and Blue Shield | 0 of 74 | No tier listed | 0 |
| Wellpoint | 0 of 63 | No tier listed | 0 |
| Priority Health Medicare | 40 of 40 | Tier 3 | 0 |
| CarePlus Health Plans, Inc. | 0 of 37 | No tier listed | 0 |
| Zing Health | 36 of 36 | Tier 3 | 0 |
| Capital Blue Cross | 35 of 35 | Tier 3 | 0 |
| Prominence Health Plan | 0 of 29 | No tier listed | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 0 of 26 | No tier listed | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 3 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 94 of 114 | 82.5% |
| Alaska | 5 of 9 | 55.6% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 92 of 147 | 62.6% |
| Arkansas | 59 of 85 | 69.4% |
| California | 166 of 397 | 41.8% |
| Colorado | 66 of 106 | 62.3% |
| Connecticut | 40 of 54 | 74.1% |
| Delaware | 32 of 43 | 74.4% |
| District of Columbia | 8 of 12 | 66.7% |
| Florida | 354 of 545 | 65% |
| Georgia | 99 of 149 | 66.4% |
| Guam | 1 of 1 | 100% |
| Hawaii | 35 of 50 | 70% |
| Idaho | 25 of 45 | 55.6% |
| Illinois | 94 of 132 | 71.2% |
| Indiana | 78 of 138 | 56.5% |
| Iowa | 52 of 64 | 81.3% |
| Kansas | 62 of 84 | 73.8% |
| Kentucky | 60 of 121 | 49.6% |
| Louisiana | 74 of 125 | 59.2% |
| Maine | 31 of 52 | 59.6% |
| Maryland | 31 of 49 | 63.3% |
| Massachusetts | 75 of 89 | 84.3% |
| Michigan | 159 of 182 | 87.4% |
| Minnesota | 38 of 63 | 60.3% |
| Mississippi | 79 of 104 | 76% |
| Missouri | 119 of 170 | 70% |
| Montana | 6 of 27 | 22.2% |
| Nebraska | 39 of 51 | 76.5% |
| Nevada | 46 of 100 | 46% |
| New Hampshire | 15 of 25 | 60% |
| New Jersey | 57 of 73 | 78.1% |
| New Mexico | 50 of 68 | 73.5% |
| New York | 169 of 215 | 78.6% |
| North Carolina | 138 of 176 | 78.4% |
| North Dakota | 15 of 26 | 57.7% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 107 of 171 | 62.6% |
| Oklahoma | 51 of 81 | 63% |
| Oregon | 59 of 92 | 64.1% |
| Pennsylvania | 226 of 323 | 70% |
| Puerto Rico | 20 of 64 | 31.3% |
| Rhode Island | 25 of 29 | 86.2% |
| South Carolina | 65 of 89 | 73% |
| South Dakota | 17 of 30 | 56.7% |
| Tennessee | 101 of 156 | 64.7% |
| Texas | 278 of 407 | 68.3% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 34 of 53 | 64.2% |
| Vermont | 6 of 14 | 42.9% |
| Virginia | 78 of 144 | 54.2% |
| Washington | 72 of 114 | 63.2% |
| West Virginia | 36 of 69 | 52.2% |
| Wisconsin | 66 of 96 | 68.8% |
| Wyoming | 6 of 13 | 46.2% |
Medicare Part D paid for 1,118,547 30-day fills of Incruse in 2024 for about 185,543 enrollees, at an average total cost of $335.46 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Incruse and the rest of a client's list on every plan in their county.
Estimate Incruse costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.